• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Estrogen activates invasiveness of endometrial cancel cells to the interstitium.

作者信息

Fujimoto J, Hori M, Ichigo S, Morishita S, Tamaya T

机构信息

Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu City, Japan.

出版信息

Invasion Metastasis. 1995;15(3-4):135-43.

PMID:8621269
Abstract

Invasiveness of endometrial cancer cells such as Ishikawa, HEC-1-A and HHUA cells, to the interstitium was significantly enhanced by estradiol, while medroxyprogesterone acetate (MPA) significantly diminished the estradiol-enhanced invasive potential. All of these endometrial cancer cells possess estrogen receptors. It is suggested that invasiveness to the interstitium, and consequently infiltration to the uterine myometrium (which means local advance) are activated by estradiol via a mechanism related to the estrogen receptor, and that MPA as an antiestrogen agent partly inactivates the invasive ability.

摘要

相似文献

1
Estrogen activates invasiveness of endometrial cancel cells to the interstitium.
Invasion Metastasis. 1995;15(3-4):135-43.
2
Estrogen activates migration potential of endometrial cancer cells through basement membrane.雌激素通过基底膜激活子宫内膜癌细胞的迁移潜能。
Tumour Biol. 1996;17(1):48-57. doi: 10.1159/000217966.
3
Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.替勃龙及其代谢产物对石川细胞中血管生成素-1、Tie-2和肿瘤坏死因子-α mRNA的影响。替勃龙对子宫内膜作用的意义。
Maturitas. 2007 Aug 20;57(4):338-46. doi: 10.1016/j.maturitas.2007.03.002. Epub 2007 May 2.
4
Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro.基质金属蛋白酶在体外对子宫内膜癌细胞侵袭的定位
Gynecol Oncol. 2001 Sep;82(3):442-9. doi: 10.1006/gyno.2001.6294.
5
Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.长期醋酸甲羟孕酮治疗增强子宫内膜癌中的表皮生长因子受体信号传导。
Gynecol Oncol. 2007 Apr;105(1):45-54. doi: 10.1016/j.ygyno.2006.12.014. Epub 2007 Jan 22.
6
Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.使用反义雌激素受体寡脱氧核糖核苷酸抑制子宫内膜癌细胞生长。
Anticancer Res. 2002 Nov-Dec;22(6C):3993-4003.
7
The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.粒细胞巨噬细胞集落刺激因子在子宫内膜癌中的表达、作用及其与转化生长因子-β的相互作用
Gynecol Oncol. 2001 May;81(2):301-9. doi: 10.1006/gyno.2001.6161.
8
Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.孕酮受体A和B的表达以及孕激素治疗对裸鼠子宫内膜癌细胞生长和扩散的影响
Endocr Relat Cancer. 2004 Dec;11(4):831-41. doi: 10.1677/erc.1.00844.
9
Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.一种与他莫昔芬相关的新型临床相关抗雌激素(GW5638)对体内乳腺癌和子宫内膜癌生长的影响。
Clin Cancer Res. 2002 Jun;8(6):1995-2001.
10
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.在雌激素和孕激素反应性子宫内膜癌细胞系中,激素替代疗法药物替勃龙的作用与醋酸甲羟孕酮非常相似。
J Mol Endocrinol. 2006 Dec;37(3):405-13. doi: 10.1677/jme.1.02057.

引用本文的文献

1
Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells.叉头框转录因子 A1 与子宫内膜癌的淋巴结状态呈负相关,并抑制子宫内膜癌细胞的增殖和迁移。
Cancer Sci. 2012 Apr;103(4):806-12. doi: 10.1111/j.1349-7006.2012.02201.x. Epub 2012 Feb 7.
2
HEC-1 cells.人子宫内膜癌细胞系HEC-1
Hum Cell. 2002 Jun;15(2):81-95. doi: 10.1111/j.1749-0774.2002.tb00103.x.